Angel® Catheter Early Feasibility Clinical Study

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Pulmonary EmbolismDeep Vein ThrombosisVenous Thromboembolism
Interventions
DEVICE

Angel® Catheter

The Angel® Catheter combines the functions of an inferior vena cava (IVC) filter and a multi-lumen central venous catheter (CVC). The device is designed to be placed in the inferior vena cava, via the femoral vein, for the prevention of Pulmonary Embolism (PE), and for access to the central venous system. The device is intended for short-term use (less than 30 days) and must be removed before hospital discharge.

Trial Locations (4)

39216

University of Mississippi Medical Center, Jackson

77030

University of Texas Houston, Houston

97239

Oregon Health and Science University, Portland

75390-9158

University of Texas Southwestern Medical Center - Dallas, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BiO2 Medical

INDUSTRY

NCT01847196 - Angel® Catheter Early Feasibility Clinical Study | Biotech Hunter | Biotech Hunter